GlobeStar Therapeutics CorporationGlobeStar Therapeutics CorporationGlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

No trades
See on Supercharts
Market capitalization
‪372.33 K‬USD
−0.0009USD
‪−1.95 M‬USD
0.00USD
‪1.22 B‬
Beta (1Y)
2.41

About GlobeStar Therapeutics Corporation


CEO
James C. Katzaroff
Headquarters
Richland
Founded
2011
FIGI
BBG001PR6G53
GlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company was founded by David P. Summers in 2011 and is headquartered in Richland, WA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GSTC is 0.0004 USD — it has increased by 33.33% in the past 24 hours. Watch GlobeStar Therapeutics Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange GlobeStar Therapeutics Corporation stocks are traded under the ticker GSTC.
GSTC stock has risen by 14.29% compared to the previous week, the last month showed zero change in price, over the last year GlobeStar Therapeutics Corporation has showed a −75.00% decrease.
GSTC reached its all-time high on Jan 17, 2012 with the price of 5,600.0000 USD, and its all-time low was 0.0002 USD and was reached on Oct 7, 2024. View more price dynamics on GSTC chart.
See other stocks reaching their highest and lowest prices.
GSTC stock is 33.33% volatile and has beta coefficient of 2.41. Track GlobeStar Therapeutics Corporation stock price on the chart and check out the list of the most volatile stocks — is GlobeStar Therapeutics Corporation there?
Yes, you can track GlobeStar Therapeutics Corporation financials in yearly and quarterly reports right on TradingView.
GSTC net income for the last quarter is ‪−197.66 K‬ USD, while the quarter before that showed ‪−174.96 K‬ USD of net income which accounts for −12.97% change. Track more GlobeStar Therapeutics Corporation financial stats to get the full picture.
No, GSTC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GSTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GlobeStar Therapeutics Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GlobeStar Therapeutics Corporation technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GlobeStar Therapeutics Corporation stock shows the sell signal. See more of GlobeStar Therapeutics Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.